Analyst Ratings for Corcept Therapeutics (CORT) [Neutrals]
CORT Rating Summary
CORT Price Target Summary
- Highest: $42.00 (Truist Securities)
- Lowest: $25.00 (Leerink Partners)
- Average: $35.60
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$35.60 (+46.4%)
* Over Last 12-Mos
Rating Score: 4.1 / 10 Percentile Rank: 41%
Rating Score: 4.1 / 10 Percentile Rank: 41%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/6/2023 | Truist Securities » Updated 2/16/2024 |
Joon Lee | Downgrade | Hold (Buy) |
42.00 (36.00) |
25.62 (24.31) |
-5.11% | Details |
4/11/2023 | Leerink Partners | Roanna Ruiz | New Coverage | Market Perform (N/A) |
25.00 (N/A) |
22.63 (24.31) |
7.42% | Details |